Stocks · Health care · Pharmaceutical Preparations

PTC THERAPEUTICS, INC.

PTCT Clue Score78
United States Fiscal year ends December CIK 0001070081
64.70
+3.42%
Close, 9 Oct 2026 · USD

Price, with every insider trade on it

Closing prices, 12 months · point at a dot for who traded, or at the line for the close
64.70 on 9 Oct 2026
90 76 62 Oct 2025 Apr 2026 Oct 2026 13 Oct 2025 $66.06 14 Oct 2025 $66.09 15 Oct 2025 $68.51 16 Oct 2025 $66.82 17 Oct 2025 $65.95 20 Oct 2025 $68.36 21 Oct 2025 $67.17 22 Oct 2025 $66.52 23 Oct 2025 $66.80 24 Oct 2025 $66.40 27 Oct 2025 $67.08 28 Oct 2025 $67.49 29 Oct 2025 $67.35 30 Oct 2025 $68.11 31 Oct 2025 $68.31 3 Nov 2025 $67.93 4 Nov 2025 $67.72 5 Nov 2025 $71.77 6 Nov 2025 $72.59 7 Nov 2025 $71.78 10 Nov 2025 $72.48 11 Nov 2025 $73.82 12 Nov 2025 $74.95 13 Nov 2025 $74.95 14 Nov 2025 $75.30 17 Nov 2025 $75.60 18 Nov 2025 $76.69 19 Nov 2025 $75.60 20 Nov 2025 $76.46 21 Nov 2025 $78.47 24 Nov 2025 $79.83 25 Nov 2025 $82.93 26 Nov 2025 $86.25 28 Nov 2025 $85.99 1 Dec 2025 $79.20 2 Dec 2025 $78.50 3 Dec 2025 $75.76 4 Dec 2025 $77.85 5 Dec 2025 $77.26 8 Dec 2025 $76.91 9 Dec 2025 $73.47 10 Dec 2025 $74.10 11 Dec 2025 $75.44 12 Dec 2025 $75.64 15 Dec 2025 $76.25 16 Dec 2025 $75.42 17 Dec 2025 $74.94 18 Dec 2025 $74.59 19 Dec 2025 $78.57 22 Dec 2025 $78.90 23 Dec 2025 $77.70 24 Dec 2025 $78.37 26 Dec 2025 $78.56 29 Dec 2025 $77.64 30 Dec 2025 $76.19 31 Dec 2025 $75.96 2 Jan 2026 $76.74 5 Jan 2026 $76.76 6 Jan 2026 $76.70 7 Jan 2026 $77.24 8 Jan 2026 $76.85 9 Jan 2026 $77.53 12 Jan 2026 $77.59 13 Jan 2026 $75.40 14 Jan 2026 $77.29 15 Jan 2026 $75.64 16 Jan 2026 $72.48 20 Jan 2026 $73.07 21 Jan 2026 $75.56 22 Jan 2026 $76.17 23 Jan 2026 $75.25 26 Jan 2026 $76.23 27 Jan 2026 $75.49 28 Jan 2026 $75.60 29 Jan 2026 $76.43 30 Jan 2026 $75.53 2 Feb 2026 $74.88 3 Feb 2026 $74.83 4 Feb 2026 $73.91 5 Feb 2026 $72.36 6 Feb 2026 $74.68 9 Feb 2026 $74.16 10 Feb 2026 $72.14 11 Feb 2026 $70.92 12 Feb 2026 $70.70 13 Feb 2026 $69.45 17 Feb 2026 $69.17 18 Feb 2026 $68.93 19 Feb 2026 $69.90 20 Feb 2026 $70.66 23 Feb 2026 $70.50 24 Feb 2026 $68.98 25 Feb 2026 $67.76 26 Feb 2026 $68.10 27 Feb 2026 $68.19 2 Mar 2026 $66.37 3 Mar 2026 $64.39 4 Mar 2026 $64.29 5 Mar 2026 $63.33 6 Mar 2026 $62.82 9 Mar 2026 $68.40 10 Mar 2026 $68.56 11 Mar 2026 $65.67 12 Mar 2026 $63.36 13 Mar 2026 $64.49 16 Mar 2026 $66.71 17 Mar 2026 $67.45 18 Mar 2026 $67.00 19 Mar 2026 $67.08 20 Mar 2026 $65.30 23 Mar 2026 $66.42 24 Mar 2026 $64.54 25 Mar 2026 $66.75 26 Mar 2026 $67.00 27 Mar 2026 $66.13 30 Mar 2026 $65.64 31 Mar 2026 $68.13 1 Apr 2026 $68.75 2 Apr 2026 $67.77 6 Apr 2026 $68.90 7 Apr 2026 $69.58 8 Apr 2026 $71.26 9 Apr 2026 $70.85 10 Apr 2026 $68.69 13 Apr 2026 $70.42 14 Apr 2026 $73.01 15 Apr 2026 $73.57 16 Apr 2026 $71.70 17 Apr 2026 $72.43 20 Apr 2026 $72.32 21 Apr 2026 $70.63 22 Apr 2026 $70.85 23 Apr 2026 $68.59 24 Apr 2026 $68.23 27 Apr 2026 $69.22 28 Apr 2026 $70.26 29 Apr 2026 $64.55 30 Apr 2026 $65.06 1 May 2026 $65.15 4 May 2026 $65.49 5 May 2026 $65.04 6 May 2026 $66.57 7 May 2026 $64.49 8 May 2026 $73.69 11 May 2026 $76.85 12 May 2026 $75.02 13 May 2026 $73.46 14 May 2026 $72.72 15 May 2026 $71.47 18 May 2026 $70.15 19 May 2026 $70.31 20 May 2026 $71.02 21 May 2026 $69.79 22 May 2026 $68.81 26 May 2026 $67.65 27 May 2026 $70.66 28 May 2026 $71.05 29 May 2026 $73.85 1 Jun 2026 $73.80 2 Jun 2026 $68.23 3 Jun 2026 $68.68 4 Jun 2026 $70.64 5 Jun 2026 $70.97 8 Jun 2026 $70.87 9 Jun 2026 $73.68 10 Jun 2026 $73.35 11 Jun 2026 $74.71 12 Jun 2026 $75.14 15 Jun 2026 $76.77 16 Jun 2026 $73.27 17 Jun 2026 $78.53 18 Jun 2026 $78.98 22 Jun 2026 $80.96 23 Jun 2026 $82.13 24 Jun 2026 $84.41 25 Jun 2026 $84.51 26 Jun 2026 $84.43 29 Jun 2026 $81.57 30 Jun 2026 $81.57 1 Jul 2026 $81.35 2 Jul 2026 $83.31 6 Jul 2026 $85.44 7 Jul 2026 $89.20 8 Jul 2026 $88.57 9 Jul 2026 $89.55 10 Jul 2026 $84.85 13 Jul 2026 $81.33 14 Jul 2026 $78.06 15 Jul 2026 $78.84 16 Jul 2026 $78.52 17 Jul 2026 $78.59 20 Jul 2026 $78.01 21 Jul 2026 $78.50 22 Jul 2026 $78.40 23 Jul 2026 $78.45 24 Jul 2026 $76.82 27 Jul 2026 $75.80 28 Jul 2026 $75.39 29 Jul 2026 $74.49 30 Jul 2026 $75.52 31 Jul 2026 $68.01 3 Aug 2026 $68.12 4 Aug 2026 $69.10 5 Aug 2026 $69.21 6 Aug 2026 $70.85 7 Aug 2026 $73.31 10 Aug 2026 $74.63 11 Aug 2026 $73.70 12 Aug 2026 $72.64 13 Aug 2026 $71.97 14 Aug 2026 $71.70 17 Aug 2026 $72.88 18 Aug 2026 $72.63 19 Aug 2026 $73.67 20 Aug 2026 $70.52 21 Aug 2026 $69.82 24 Aug 2026 $71.06 25 Aug 2026 $73.47 26 Aug 2026 $72.69 27 Aug 2026 $71.81 28 Aug 2026 $70.09 31 Aug 2026 $69.54 1 Sep 2026 $70.56 2 Sep 2026 $71.79 3 Sep 2026 $71.40 4 Sep 2026 $69.30 8 Sep 2026 $68.81 9 Sep 2026 $67.57 10 Sep 2026 $67.37 11 Sep 2026 $66.06 14 Sep 2026 $66.48 15 Sep 2026 $65.65 16 Sep 2026 $67.59 17 Sep 2026 $68.00 18 Sep 2026 $65.37 21 Sep 2026 $65.26 22 Sep 2026 $65.96 23 Sep 2026 $62.34 24 Sep 2026 $62.28 25 Sep 2026 $62.67 28 Sep 2026 $65.95 29 Sep 2026 $64.96 30 Sep 2026 $64.78 1 Oct 2026 $64.13 2 Oct 2026 $63.46 5 Oct 2026 $63.65 6 Oct 2026 $63.70 7 Oct 2026 $63.23 8 Oct 2026 $62.56 9 Oct 2026 $64.70 Reeve Emma Director Sold on a plan $1.09M 30 Oct 2025 · at $69.50 · 70.2% of stake Reeve Emma Director Sold on a plan $546.31K 12 Nov 2025 · at $74.50 · 52.4% of stake Boulding Mark Elliott EXEC. VP AND CLO Sold on a plan $213.69K 17 Nov 2025 · at $75.99 · 2.6% of stake Reeve Emma Director Sold on a plan $795.00K 21 Nov 2025 · at $79.50 · 60.0% of stake Jacobson Allan Steven Director Sold on a plan $945.74K 24 Nov 2025 · at $80.14 · 40.3% of stake Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER Sold on a plan $2.85M 24 Nov 2025 · at $80.18 · 26.1% of stake Jacobson Allan Steven Director Sold on a plan $1.19M 25 Nov 2025 · at $83.55 · 44.9% of stake Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER Sold on a plan $6.00M 25 Nov 2025 · at $83.44 · 41.7% of stake Klein Matthew B. CHIEF EXECUTIVE OFFICER Sold on a plan $271.05K 2 Dec 2025 · at $79.07 · 1.0% of stake Reeve Emma Director Sold on a plan $57.63K 3 Dec 2025 · at $78.62 · 9.9% of stake Pauwels Eric CHIEF BUSINESS OFFICER Sold on a plan $3.04M 17 Dec 2025 · at $75.43 · 36.4% of stake Pauwels Eric CHIEF BUSINESS OFFICER Sold on a plan $240.35K 18 Dec 2025 · at $75.06 · 4.4% of stake Pauwels Eric CHIEF BUSINESS OFFICER Sold on a plan $1.58M 19 Dec 2025 · at $77.26 · 22.6% of stake Klein Matthew B. CHIEF EXECUTIVE OFFICER Sold on a plan $619.94K 30 Dec 2025 · at $76.64 · 2.3% of stake STEELE GLENN JR MD PHD Director Sold on a plan $916.20K 2 Jan 2026 · at $76.35 · 39.3% of stake Reeve Emma Director Sold on a plan $55.78K 5 Jan 2026 · at $76.00 · 6.4% of stake Boulding Mark Elliott EXEC. VP AND CLO Sold on a plan $171.19K 5 Jan 2026 · at $75.55 · 1.8% of stake Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER Sold on a plan $4.16K 6 Jan 2026 · at $76.95 · 0.8% of stake Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER Sold on a plan $98.42K 6 Jan 2026 · at $76.95 · 1.1% of stake Golden Lee Scott EVP & CHIEF MEDICAL OFFICER Sold on a plan $103.11K 6 Jan 2026 · at $76.95 · 1.4% of stake Utter Christine Marie SVP, CHIEF ACCOUNTING OFFICER Sold on a plan $106.27K 6 Jan 2026 · at $76.95 · 1.8% of stake Boulding Mark Elliott EXEC. VP AND CLO Sold on a plan $133.82K 6 Jan 2026 · at $76.95 · 1.4% of stake Pauwels Eric CHIEF BUSINESS OFFICER Sold on a plan $137.66K 6 Jan 2026 · at $76.95 · 2.0% of stake Gravier Pierre CHIEF FINANCIAL OFFICER Sold on a plan $164.60K 6 Jan 2026 · at $76.95 · 2.3% of stake Klein Matthew B. CHIEF EXECUTIVE OFFICER Sold on a plan $396.22K 6 Jan 2026 · at $76.95 · 1.3% of stake Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER Sold on a plan $4.03K 7 Jan 2026 · at $77.48 · 0.8% of stake Golden Lee Scott EVP & CHIEF MEDICAL OFFICER Sold on a plan $49.74K 7 Jan 2026 · at $77.48 · 0.7% of stake Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER Sold on a plan $79.49K 7 Jan 2026 · at $77.48 · 0.9% of stake Utter Christine Marie SVP, CHIEF ACCOUNTING OFFICER Sold on a plan $95.65K 7 Jan 2026 · at $77.45 · 1.6% of stake Pauwels Eric CHIEF BUSINESS OFFICER Sold on a plan $104.75K 7 Jan 2026 · at $77.48 · 1.5% of stake Klein Matthew B. CHIEF EXECUTIVE OFFICER Sold on a plan $233.68K 7 Jan 2026 · at $77.48 · 0.8% of stake Boulding Mark Elliott EXEC. VP AND CLO Sold on a plan $377.83K 7 Jan 2026 · at $77.44 · 4.0% of stake Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER Sold on a plan $4.51K 8 Jan 2026 · at $76.45 · 0.9% of stake Golden Lee Scott EVP & CHIEF MEDICAL OFFICER Sold on a plan $66.21K 8 Jan 2026 · at $76.45 · 0.9% of stake Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER Sold on a plan $67.35K 8 Jan 2026 · at $76.45 · 0.8% of stake Utter Christine Marie SVP, CHIEF ACCOUNTING OFFICER Sold on a plan $79.05K 8 Jan 2026 · at $76.45 · 1.4% of stake Klein Matthew B. CHIEF EXECUTIVE OFFICER Sold on a plan $192.20K 8 Jan 2026 · at $76.45 · 0.6% of stake Boulding Mark Elliott EXEC. VP AND CLO Sold on a plan $308.76K 8 Jan 2026 · at $76.56 · 3.4% of stake Pauwels Eric CHIEF BUSINESS OFFICER Sold on a plan $352.06K 8 Jan 2026 · at $76.50 · 5.3% of stake Pauwels Eric CHIEF BUSINESS OFFICER Sold on a plan $133.30K 9 Jan 2026 · at $77.41 · 2.1% of stake Boulding Mark Elliott EXEC. VP AND CLO Sold on a plan $180.32K 9 Jan 2026 · at $77.93 · 2.0% of stake Pauwels Eric CHIEF BUSINESS OFFICER Sold on a plan $80.59K 12 Jan 2026 · at $78.70 · 1.3% of stake Boulding Mark Elliott EXEC. VP AND CLO Sold on a plan $194.91K 17 Feb 2026 · at $69.29 · 2.5% of stake Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER Sold on a plan $4.51K 18 Feb 2026 · at $69.36 · 1.0% of stake Golden Lee Scott EVP & CHIEF MEDICAL OFFICER Sold on a plan $172.29K 18 Feb 2026 · at $69.36 · 2.7% of stake Utter Christine Marie SVP, CHIEF ACCOUNTING OFFICER Sold on a plan $172.98K 18 Feb 2026 · at $69.36 · 3.4% of stake Gravier Pierre CHIEF FINANCIAL OFFICER Sold on a plan $207.53K 18 Feb 2026 · at $69.36 · 3.3% of stake Pauwels Eric CHIEF BUSINESS OFFICER Sold on a plan $209.40K 18 Feb 2026 · at $69.36 · 3.8% of stake Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER Sold on a plan $211.96K 18 Feb 2026 · at $69.36 · 2.7% of stake Boulding Mark Elliott EXEC. VP AND CLO Sold on a plan $213.70K 18 Feb 2026 · at $69.36 · 2.8% of stake Klein Matthew B. CHIEF EXECUTIVE OFFICER Sold on a plan $511.25K 18 Feb 2026 · at $69.36 · 1.9% of stake Boulding Mark Elliott EXEC. VP AND CLO Sold on a plan $209.76K 19 Feb 2026 · at $69.48 · 2.8% of stake Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER Sold on a plan $252.82K 5 Mar 2026 · at $63.38 · 59.3% of stake Okey Stephanie Director Sold on a plan $401.39K 5 Mar 2026 · at $63.38 · 44.2% of stake Golden Lee Scott EVP & CHIEF MEDICAL OFFICER Sold on a plan $633.80K 5 Mar 2026 · at $63.38 · 11.1% of stake Okey Stephanie Director Sold on a plan $1.06M 10 Mar 2026 · at $70.00 · 65.5% of stake Klein Matthew B. CHIEF EXECUTIVE OFFICER Sold on a plan $170.58K 12 Mar 2026 · at $64.08 · 0.7% of stake Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER Sold on a plan $3.59M 1 Apr 2026 · at $69.04 · 46.4% of stake Golden Lee Scott EVP & CHIEF MEDICAL OFFICER Sold on a plan $56.36K 2 Apr 2026 · at $67.99 · 1.0% of stake Boulding Mark Elliott EXEC. VP AND CLO Sold on a plan $157.29K 6 Apr 2026 · at $69.45 · 2.1% of stake Klein Matthew B. CHIEF EXECUTIVE OFFICER Sold on a plan $202.09K 21 Apr 2026 · at $70.91 · 0.7% of stake Boulding Mark Elliott EXEC. VP AND CLO Sold on a plan $279.57K 8 May 2026 · at $78.97 · 3.3% of stake Klein Matthew B. CHIEF EXECUTIVE OFFICER Sold on a plan $917.15K 14 May 2026 · at $72.95 · 3.1% of stake Boulding Mark Elliott EXEC. VP AND CLO Sold on a plan $202.96K 15 May 2026 · at $72.18 · 2.6% of stake Pauwels Eric CHIEF BUSINESS OFFICER Sold on a plan $1.60M 10 Jun 2026 · at $75.00 · 22.5% of stake Boulding Mark Elliott EXEC. VP AND CLO Sold on a plan $822.87K 17 Jun 2026 · at $78.65 · 9.0% of stake Utter Christine Marie SVP, CHIEF ACCOUNTING OFFICER Sold on a plan $1.49M 17 Jun 2026 · at $75.56 · 21.9% of stake Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER Sold on a plan $1.92M 22 Jun 2026 · at $80.90 · 28.3% of stake Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER Sold on a plan $452.61K 24 Jun 2026 · at $85.03 · 8.1% of stake Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER Sold on a plan $1.80M 25 Jun 2026 · at $85.97 · 25.8% of stake Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER Sold on a plan $693.15K 26 Jun 2026 · at $85.26 · 11.9% of stake Boulding Mark Elliott EXEC. VP AND CLO Sold on a plan $432.12K 6 Jul 2026 · at $85.08 · 4.6% of stake Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER Sold on a plan $1.91M 6 Jul 2026 · at $86.00 · 26.9% of stake Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER Sold on a plan $2.19M 7 Jul 2026 · at $88.89 · 29.0% of stake Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER Sold on a plan $222.38K 9 Jul 2026 · at $90.25 · 3.9% of stake Smith Mary L. Director Sold on a plan $1.43M 9 Jul 2026 · at $90.00 · 42.1% of stake Gravier Pierre CHIEF FINANCIAL OFFICER Sold on a plan $280.74K 14 Jul 2026 · at $80.35 · 4.0% of stake Klein Matthew B. CHIEF EXECUTIVE OFFICER Sold on a plan $705.72K 4 Aug 2026 · at $68.57 · 2.6% of stake Boulding Mark Elliott EXEC. VP AND CLO Sold on a plan $204.13K 17 Aug 2026 · at $72.57 · 2.6% of stake SCHMERTZLER MICHAEL Director Sold on a plan $916.55K 19 Aug 2026 · at $73.32 · 0.9% of stake SCHMERTZLER MICHAEL Director Sold on a plan $888.86K 20 Aug 2026 · at $71.11 · 0.9% of stake SCHMERTZLER MICHAEL Director Sold on a plan $911.73K 26 Aug 2026 · at $72.94 · 0.9% of stake SCHMERTZLER MICHAEL Director Sold on a plan $894.78K 27 Aug 2026 · at $71.58 · 0.9% of stake SCHMERTZLER MICHAEL Director Sold on a plan $678.40K 9 Sep 2026 · at $67.84 · 0.7% of stake SCHMERTZLER MICHAEL Director Sold on a plan $673.40K 10 Sep 2026 · at $67.34 · 0.8% of stake SCHMERTZLER MICHAEL Director Sold on a plan $671.19K 16 Sep 2026 · at $67.12 · 0.8% of stake SCHMERTZLER MICHAEL Director Sold on a plan $678.53K 17 Sep 2026 · at $67.85 · 0.8% of stake STEELE GLENN JR MD PHD Director Sold on a plan $781.92K 30 Sep 2026 · at $65.16 · 34.8% of stake Boulding Mark Elliott EXEC. VP AND CLO Sold on a plan $104.88K 5 Oct 2026 · at $64.03 · 1.5% of stake Boulding Mark Elliott EXEC. VP AND CLO Sold on a plan $27.91K 6 Oct 2026 · at $64.16 · 0.4% of stake SCHMERTZLER MICHAEL Director Sold on a plan $158.48K 7 Oct 2026 · at $63.39 · 0.2% of stake
0 buys0 sales at will91 planned sales

Key numbers

Fiscal year 2025, ended 31 Dec 2025, as filed
Revenue
$1.73B
Net income
$682.64M
Free cash flow
$702.34M
Operating margin
50.1%
Net margin
39.4%
Return on capital
137.7%
Revenue growth, 1 yr
114.5%
Revenue growth, 5 yr
35.4% a year

Revenue and net income

Fiscal years, as filed with the SEC · point at a year for the detail
381M -438M FY20 Fiscal year 2020 Revenue $380.77M Net income $438.16M Margin -115.1% 539M -524M FY21 Fiscal year 2021 Revenue $538.59M Net income $523.90M Margin -97.3% · growth +41.4% 699M -559M FY22 Fiscal year 2022 Revenue $698.80M Net income $559.02M Margin -80.0% · growth +29.7% 938M -627M FY23 Fiscal year 2023 Revenue $937.82M Net income $626.60M Margin -66.8% · growth +34.2% 807M -363M FY24 Fiscal year 2024 Revenue $806.78M Net income $363.30M Margin -45.0% · growth -14.0% 1.7B 683M FY25 Fiscal year 2025 Revenue $1.73B Net income $682.64M Margin 39.4% · growth +114.5%
RevenueNet incomeLoss

Latest insider transactions

From Form 4, most recent first
All of them →
DateInsiderTypeValueOf own stake
7 Oct 2026 SCHMERTZLER MICHAEL
Director
Sold on a plan $158.48K 0.2%
6 Oct 2026 Boulding Mark Elliott
EXEC. VP AND CLO
Sold on a plan $27.91K 0.4%
5 Oct 2026 Boulding Mark Elliott
EXEC. VP AND CLO
Sold on a plan $104.88K 1.5%
30 Sep 2026 STEELE GLENN JR MD PHD
Director
Sold on a plan $781.92K 34.8%
17 Sep 2026 SCHMERTZLER MICHAEL
Director
Sold on a plan $678.53K 0.8%
16 Sep 2026 SCHMERTZLER MICHAEL
Director
Sold on a plan $671.19K 0.8%